Using AI to Improve Weekly Symptom Tracking in Pelvic Radiotherapy
Evaluation of AI-Enhanced Symptom Summarization in Weekly Radiotherapy Consultations: A Comparative Study
This study is testing whether an AI tool can help make weekly check-ins for patients getting pelvic radiotherapy more accurate and efficient compared to standard methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | jaide Industry-sponsored |
| Locations | 1 site (Rio de Janeiro) |
| Trial ID | NCT06525181 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an AI-enabled symptom summary tool in enhancing the accuracy and efficiency of weekly consultations for patients undergoing pelvic radiotherapy. Patients will receive both standard and AI-assisted consultations, with summaries generated using the OpenAI GPT-4 API. The accuracy of these summaries will be compared by blinded oncologists using a validated quality assessment tool, while both patients and doctors will provide feedback on their satisfaction with the summaries. The primary goal is to determine if the AI tool can match traditional methods in accuracy while saving time.
Who should consider this trial
Good fit: Ideal candidates for this study are patients currently undergoing radiotherapy for pelvic cancer.
Not a fit: Patients who have undergone pelvic reirradiation or surgery will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could streamline the symptom tracking process for patients undergoing radiotherapy, leading to improved care and potentially better treatment outcomes.
How similar studies have performed: Other studies have shown promise in using AI for medical documentation, suggesting that this approach may yield beneficial results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients undergoing radiotherapy in the pelvic region. Exclusion Criteria: Cases of pelvic reirradiation or operated cases.
Where this trial is running
Rio de Janeiro
- Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA — Rio de Janeiro, Brazil (Recruiting)
Study contacts
- Study coordinator: Rachele Grazziotin, MD
- Email: cep@inca.gov.br
- Phone: (21)3207-4550
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.